Arrowhead Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
11.02.25
/
50%
€17.89
Target price
11.02.26
€40.58
Performance (%)
84.24%
Price
04.11.25
€32.96
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc. has seen massive gains of 84.24%. This prediction currently runs until 11.02.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | -2.051% | -2.051% |
| iShares Core DAX® | -1.602% | -2.113% |
| iShares Nasdaq 100 | -0.781% | 4.974% |
| iShares Nikkei 225® | 1.289% | 9.118% |
| iShares S&P 500 | -0.258% | 3.131% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $42.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.10
08.08.25
08.08.25
€32.59
08.08.26
08.08.26
133.76%
04.11.25
04.11.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.62
26.09.24
26.09.24
€37.69
26.09.25
26.09.25
58.05%
27.09.25
27.09.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€29.40
07.02.24
07.02.24
€46.44
07.02.25
07.02.25
-32.70%
08.02.25
08.02.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.94
16.01.24
16.01.24
€45.92
16.01.25
16.01.25
-41.56%
17.01.25
17.01.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.00
30.11.23
30.11.23
€45.85
30.11.24
30.11.24
11.32%
01.12.24
01.12.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.07
08.08.23
08.08.23
€54.74
08.08.24
08.08.24
-10.25%
09.08.24
09.08.24